|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||300.07 - 303.33|
|52-week range||300.07 - 303.33|
|Beta (5Y monthly)||0.46|
|PE ratio (TTM)||28.71|
|Earnings date||03 May 2023 - 08 May 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
CRISPR Therapeutics (CRSP), a top-ranked stock at present, is developing its lead pipeline candidate to treat TDT and SCD.
Critics of Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) believe that the company is lagging behind OpenAI and Microsoft in the artificial intelligence (AI) race. It could be a huge mistake to underestimate Alphabet's AI expertise or Google Search's resilience.
According to the average brokerage recommendation (ABR), one should invest in Vertex (VRTX). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?